[HB-EGF is a promising target molecule for ovarian cancer]

Fukuoka Igaku Zasshi. 2004 Nov;95(11):286-90.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Bacterial Proteins / pharmacology
  • Bacterial Proteins / therapeutic use*
  • Cell Division / genetics*
  • Drug Design*
  • Epidermal Growth Factor / antagonists & inhibitors*
  • Epidermal Growth Factor / physiology*
  • ErbB Receptors / physiology*
  • Female
  • Heparin-binding EGF-like Growth Factor
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Ligands
  • Lysophospholipids / physiology
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Signal Transduction / physiology

Substances

  • Antineoplastic Agents
  • Bacterial Proteins
  • HBEGF protein, human
  • Heparin-binding EGF-like Growth Factor
  • Intercellular Signaling Peptides and Proteins
  • Ligands
  • Lysophospholipids
  • CRM197 (non-toxic variant of diphtheria toxin)
  • Epidermal Growth Factor
  • ErbB Receptors
  • lysophosphatidic acid